Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bank Analysts Say Pfizer-AstraZeneca Merger Still Makes Sense
NY Times, NY
Tuesday, June 24, 2014 - 9:11am
tags:
Pfizer, AstraZeneca, M&A
Bristol-Myers Squibb's Oncology Opportunity
Motley Fool
Tuesday, June 24, 2014 - 9:11am
tags:
Bristol-Myers Squibb, Yervoy, melanoma
Will GlaxoSmithKline plc Become A Bid Target?
Motley Fool
Tuesday, June 24, 2014 - 9:09am
tags:
GSK, JNJ, Novartis, M&A
Merrimack Falls Steeply as Sanofi Returns Oncology Drug Rights
Yahoo/Zacks.com
Monday, June 23, 2014 - 7:52pm
tags:
Sanofi, Merrimack Pharmaceuticals, MM-121
Abbott to buy Russian drug maker Veropharm, but says it’s not tax inversion deal
Marketwatch
Monday, June 23, 2014 - 6:25pm
tags:
Russia, Abbott Labs, M&A, Veropharm
Pfizer: Pfine With Or Without AstraZeneca
Seeking Alpha
Monday, June 23, 2014 - 6:23pm
tags:
Pfizer, AstraZeneca, M&A
Analyzing The Hepatitis C Market Size: Why It May Have Bullish Implications For Gilead
Seeking Alpha
Monday, June 23, 2014 - 6:22pm
tags:
Gilead, Sovaldi, hepatitis C
Cellectis Sees Independent Future After Pfizer Deal
TheStreet.com
Monday, June 23, 2014 - 6:21pm
tags:
Cellectis, Pfizer, chimeric antigen receptor T-cell immunotherapies
Cubist Sivextro sales to benefit from lack of warnings, says JMP Securities
The Fly on the Wall
Monday, June 23, 2014 - 12:53pm
tags:
Sivextro, antibiotics, Cubist Pharmaceuticals
Some cancer docs still bill heavily for Amgen's Epogen despite safety questions
Fierce Pharma
Monday, June 23, 2014 - 12:53pm
tags:
Amgen, Epogen, anemia, Procrit, JNJ
FDA cuts back oversight of medical device data systems
Mass Device
Monday, June 23, 2014 - 12:44pm
tags:
FDA, devices
Allergan, Valeant trade rapid-fire salvos in ongoing takeover battle
Marketwatch
Monday, June 23, 2014 - 11:36am
tags:
Allergan, Valeant Pharmaceuticals, M&A
Aerie's Upcoming Catalyst - ROCKing The Way To Success
Seeking Alpha
Monday, June 23, 2014 - 11:36am
tags:
Aerie Pharma, glaucoma, Roclatan, Rhopressa, Novartis, Pfizer, Allergan
23andMe Is Moving Forward In The FDA Approval Process
Yahoo/Business Insider
Monday, June 23, 2014 - 10:19am
tags:
23andMe, FDA, diagnostics
Can pharma salvage its tarnished reputation? Survey says yes
Fierce Pharma
Monday, June 23, 2014 - 10:18am
tags:
pharma industry
Allergan advises shareholders against Valeant tender offer
Yahoo/Reuters
Monday, June 23, 2014 - 10:00am
tags:
Allergan, Valeant Pharmaceuticals, M&A
As Google, Apple Get Ready To Change Mobile Health, Some Advertisers Could Find The FDA Barring The Way
Forbes
Monday, June 23, 2014 - 9:59am
tags:
mHealth, Apple, Google, FDA
U.S. Steps Up Probes of Deals to Block Generic Drugs
Yahoo/Bloomberg
Monday, June 23, 2014 - 9:52am
tags:
generics, FTC
[video]FDA Drops the Hammer on Twitter
Motley Fool
Monday, June 23, 2014 - 9:51am
tags:
twitter, FDA, social media
FDA staff question validity of benefit seen with AstraZeneca drug
Yahoo/Reuters
Monday, June 23, 2014 - 9:42am
tags:
FDA, AstraZeneca, olaparib, ovarian cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.